In the brains of AD patients and animal models, astrocytes become reactive and exhibit aberrant activation states surrounding Aβ deposits; these cells have been shown to express high levels of GFAP and S100β markers [21, 51]. This evidence concerns the gene GFAP and Alzheimer disease.